Renal Cancer
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis
January 5, 2018
Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients
January 4, 2018
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
January 4, 2018
How Checkpoint Inhibitors Are Changing the Treatment Paradigm in Solid Tumors: What Advanced Practitioners in Oncology Need to Know
January 3, 2018
Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens
January 3, 2018
Cabozantinib: A Multi-targeted Oral Tyrosine Kinase Inhibitor
January 2, 2018
Individualized dosing with axitinib: rationale and practical guidance
December 29, 2017
99mTc-Sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide
December 27, 2017
Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial
December 26, 2017
Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison
December 25, 2017
Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting
December 22, 2017
Laser desorption/ionization MS imaging of cancer kidney tissue on silver nanoparticle-enhanced target
December 22, 2017
Incision site metastasis: Adding insult to injury
December 22, 2017